机构地区:[1]徐州医科大学,江苏省脑病生物信息重点实验室生物化学与分子生物学研究中心,徐州221004
出 处:《中国生物工程杂志》2022年第10期31-38,共8页China Biotechnology
基 金:国家自然科学基金(81100852);江苏省高等学校自然科学研究重大项目(20KJA310010)资助项目。
摘 要:目的:制备大鼠SUMO特异性蛋白酶1(sentrin-specific protease,SENP1)催化结构域(SENP1C)蛋白,并鉴定其酶活性。方法:分别以大鼠SENP1-pcDNA3.1和EGFP-pcDNA3.1重组体为模板,PCR扩增目的基因,克隆入pGEM-T载体;酶切鉴定后,再亚克隆入原核表达载体pET-28a;阳性重组体导入原核表达细胞BL-21,异丙基硫半乳糖苷(IPTG)诱导蛋白质表达;SDS-PAGE及考马斯亮蓝染色鉴定蛋白质的表达。Ni-NTA吸附纯化蛋白质并透析处理,SDS-PAGE及考马斯亮蓝染色鉴定蛋白质的纯度;1μmol/L及5μmol/L Tat-EGFP分别孵育HT22细胞不同时间,荧光显微镜下观察细胞转染情况。采用5μmol/L Tat-SENP1C预孵育HT22细胞10 h,免疫印迹检测整体蛋白质的SUMO化水平;用5μmol/L Tat-SENP1C预孵育HT22细胞或过表达Myc-Akt1和HA-SUMO1的HT22细胞10 h后,免疫沉淀和免疫印迹检测内源性和外源性Akt1与SUMO1的结合(SUMO化)。结果:Tat-SENP1C-pET-28a和Tat-EGFP-pET-28a重组原核表达载体成功构建,IPTG可以诱导蛋白质高表达;采用Ni-NTA纯化和透析可获得较高纯度的蛋白质;5μmol/L Tat-EGFP孵育HT22细胞10 h后,蛋白质穿膜效率较高;Tat-SENP1C重组蛋白可以显著降低HT22细胞中整体蛋白质的SUMO化以及内源性和外源性Akt1 SUMO化。结论:Tat-SENP1C-pET-28a和Tat-EGFP-pET-28a重组原核表达载体构建成功,且被IPTG诱导后可高效表达蛋白质;纯化的Tat-SENP1C蛋白具有较强的穿膜能力及酶活性。Objective:Preparation and enzymatic activity identification of sentrin-specific protease1(SENP1)catalytic domain(SENP1 C).Methods:The target genes were amplified by PCR from SENP1-pcDNA3.1 and EGFP-pcDNA3.1,and then cloned into pGEM-T vector.After enzyme digestion,the digested cDNAs were then subcloned into the prokaryotic expression vector pET-28 a.Next,the positive recombinants were transfected into prokaryotic expression cells BL-21,which were then induced by isopropyl thiogalactoside(IPTG).The protein expression was identified by SDS-PAGE and coomassie brilliant blue staining.The extracted proteins were purified by Ni-NTA and dialysis treatment,and the protein purity was further checked by SDS-PAGE and coomassie brilliant blue staining.HT22 cells was pre-incubated with 1μmol/L or 5μmol/L Tat-EGFP for different times,and cell transfection was observed by fluorescence microscope.After pretreatment with 5μmol/L Tat-SENP1 for 10 h,the SUMOylation of overall protein in HT22 cells was detected by immunoblot analysis.In addition,immunoprecipitation and immunoblotting were used to evaluate endogenous and exogenous Akt1-SUMO1 conjugations in HT22 cells or HT22 cells overexpressing Myc-Akt1 and HA-SUMO1.Results:Tat-SENP1 C-pET-28 a and Tat-EGFP-pET-28 a prokaryotic expression recombinants were successfully constructed,which were efficiently induced to express target proteins by IPTG.The high purity target proteins were obtained by Ni-NTA and dialysis.After incubation with 5μmol/L Tat-EGFP for 10 h,the penetration efficiency was higher in HT22 cells.Tat-SENP1 C reduced the levels of total SUMOylation and endogenous and exogenous Akt1-SUMO1 conjugations significantly.Conclusion:Tat-SENP1 C-pET-28 a and Tat-EGFP-pET-28 a prokaryotic expression recombinants were successfully constructed,and can be highly induced to express target proteins by IPTG.The purified Tat-SENP1 C retains strong membrane penetration ability and enzymatic activity.
关 键 词:SUMO特异性蛋白酶1 催化结构域 原核表达载体 去SUMO化 蛋白激酶Bα
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...